NewAmsterdam Pharma Company N.V. Stock Börse Stuttgart
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.95 EUR | +0.28% | +8.48% | +80.81% |
Sales 2024 * | 8.6M 9.24M 12.73M | Sales 2025 * | 6.3M 6.76M 9.32M | Capitalization | 1.61B 1.73B 2.38B |
---|---|---|---|---|---|
Net income 2024 * | -209M -225M -309M | Net income 2025 * | -139M -149M -206M | EV / Sales 2024 * | 187 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 255 x |
P/E ratio 2024 * |
-7.66
x | P/E ratio 2025 * |
-11.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +8.48% | ||
Current month | +8.48% | ||
1 month | -9.60% | ||
3 months | -10.05% | ||
6 months | +114.37% | ||
Current year | +80.81% |
Date | Price | Change |
---|---|---|
24-06-10 | 17.5 | -2.23% |
24-06-07 | 17.9 | +1.70% |
24-06-06 | 17.6 | +3.53% |
24-06-05 | 17 | 0.00% |
24-06-04 | 17 | +0.59% |
Delayed Quote Börse Stuttgart, June 10, 2024 at 02:12 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.70% | 22.78B | |
-10.84% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock